Early persistence of recipient stem-cells and T-cell dysregulation are associated with relapse after transplant in AML/MDS
Sariipek, N. E.; Safina, K. R.; Lu, W. S.; Li, S.; Janes, J. T.; Van Orden, M.; Livak, K. J.; Heaton, H.; Ho, V. T.; Koreth, J.; Luskin, M. R.; Griffin, G. K.; Garcia, J. S.; Lindsley, R. C.; Cutler, C.; Soiffer, R. J.; Ritz, J.; Wu, C. J.; Antin, J. H.; Lane, A. A.; Gooptu, M.; Galen, P. v.
Show abstract
Hematopoietic stem cell transplantation (HSCT) offers the best curative option for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), yet relapse remains common. Current relapse detection methods are often too late for effective intervention. To identify earlier predictors and therapeutic targets, we performed longitudinal single-cell RNA and T cell receptor (TCR) sequencing of bone marrow from 33 AML/MDS patients during post-transplant immune reconstitution, comparing those who relapsed to those who remained in remission. Persistence of recipient hematopoietic stem and progenitor cells (HSPCs) in the marrow was associated with relapse months later. These residual recipient HSPCs harbored copy number variations (CNVs), supporting their leukemic origin, and overexpressed PRAME and CALCRL compared to coexisting donor HSPCs. Further, in a subset of TP53-mutant disease, low TCR diversity with skewing toward dominant clonotypes foreshadowed relapse. These findings lay the groundwork for improved relapse prediction and nominate therapeutic targets for early post-transplant intervention.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias 97%
- Leukemia escapes immunity by imposing a Type-1 regulatory program on neoantigen-specific CD4+ T cells. 96%
- Disruption of a GATA2, TAL1, ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells 96%
Similar papers in this journal
- Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia 98%
- Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition 96%
- Distinct Tumor Necrosis Factor Alpha Receptors Dictate Stem Cell Fitness Versus Lineage Output in Dnmt3a-Mutant Clonal Hematopoiesis 96%
Similar papers in this journal
- Single cell dissection of developmental origins and transcriptional heterogeneity in B-cell acute lymphoblastic leukemia 97%
- A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma 95%
- DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression 94%
Similar papers in this journal
- Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties 98%
- AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML 97%
- Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric acute myeloid leukemia 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.